NTRK gene fusion-positive tumours are cancers with specific genetic abnormalities involving NTRK genes (NTRK1, NTRK2, NTRK3), which encode tropomyosin receptor kinase (TRK) proteins A, B, and C [74]. This evidence concerns the gene NTRK2 and cancer.